Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
The American Journal of Surgical Pathology
|
July 1, 1996
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study
D Cazals-Hatem, E Lepage, P Brice, et al.
Blood
|
August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
C Adida, C Haioun, P Gaulard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial
P Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients
C Haioun, N Mounier, B Quesnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study
C Haioun, E Lepage, C Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
The American Journal of Medicine
|
December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes
J Gabarre, M Raphael, E Lepage, et al.
Leukemia & Lymphoma
|
April 1, 1997
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte
C Gisselbrecht, C Haioun, E Lepage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
The Journal of Cell Biology
|
March 18, 2015
PAPC mediates self/non-self-distinction during Snail1-dependent tissue separation
Olivia Luu, Erich W Damm, Serge E Parent, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
The American Journal of Surgical Pathology
|
July 1, 1996
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study
D Cazals-Hatem, E Lepage, P Brice, et al.
Blood
|
August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
C Adida, C Haioun, P Gaulard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial
P Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients
C Haioun, N Mounier, B Quesnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study
C Haioun, E Lepage, C Gisselbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
The American Journal of Medicine
|
December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes
J Gabarre, M Raphael, E Lepage, et al.
Leukemia & Lymphoma
|
April 1, 1997
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte
C Gisselbrecht, C Haioun, E Lepage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte
P Feugier, A Van Hoof, C Sebban, et al.
The Journal of Cell Biology
|
March 18, 2015
PAPC mediates self/non-self-distinction during Snail1-dependent tissue separation
Olivia Luu, Erich W Damm, Serge E Parent, et al.
Page
of 13